Michael Kishbauch
Director/Miembro de la Junta en ASTRIA THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Michael D.
Kishbauch was the founder of OraPharma, Inc. founded in 1996, where he held the title of President & Chief Executive Officer in 2004.
He is currently an Independent Director at Astria Therapeutics, Inc. since 2016.
Mr. Kishbauch received his undergraduate degree from Wesleyan University and his MBA degree from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
09/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Michael Kishbauch
Empresas | Cargo | Inicio |
---|---|---|
ASTRIA THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/04/2016 |
Antiguos cargos conocidos de Michael Kishbauch.
Empresas | Cargo | Fin |
---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Director Ejecutivo | 01/09/2013 |
PROGENICS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 17/10/2019 |
TETRALOGIC PHARMACEUTICALS CORPORATION | Director/Miembro de la Junta | 01/12/2016 |
ARIAD PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/12/2008 |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Director Ejecutivo | 01/07/2004 |
Formación de Michael Kishbauch.
Wesleyan University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
ASTRIA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Ciba-Geigy Corp. | Health Technology |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Kishbauch